Cannabinoids May Play Role In Treating Depression:
“The cannabinoids Delta(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD) may exert sedative, hypnotic, anxiolytic, antidepressant, antipsychotic and anticonvulsant effects. Pure synthetic cannabinoids, such as Dronabinol and Nabilone and specific plant extracts containing THC, CBD, or a mixture of the two in known concentrations, are available and can be delivered sublingually. Controlled trials of these cannabinoids as adjunctive medication in bipolar disorder are now indicated.”
But human research is contrained… why? Because cannabis’s researched and media reported ‘correlation’ of use in this group is infered to be causative and thus cannot be self-medication.
Persons labeled “of weak moral fibre” being coupled to depressive indicators based upon an erroneous subclinical judgement are quite probably an (if not the) impediment to effective treatment where trust/empathy between patient and clinician correlates highly to successful outcomes.
MildGreens's Backup Blog 
April 29, 2008 at 6:59 pm |
Here’s another interesting article on dronabinol in people with bipolar disorder. Successful treatment of sexual dysfunction with dronabinol: a case report